Inhibition of Mcl-1 enhances cell death induced by the Bcl-2-selective inhibitor ABT-199 in acute myeloid leukemia cells

Acute myeloid leukemia (AML) is a serious disease. The 5-year survival rates remain frustratingly low (65% for children and 26% for adults). Resistance to frontline chemotherapy (usually cytarabine) often develops; therefore a new treatment modality is needed. Bcl-2 family proteins play an important...

Descripción completa

Detalles Bibliográficos
Autores principales: Luedtke, Daniel A, Niu, Xiaojia, Pan, Yihang, Zhao, Jianyun, Liu, Shuang, Edwards, Holly, Chen, Kang, Lin, Hai, Taub, Jeffrey W, Ge, Yubin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2017
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5661618/
https://www.ncbi.nlm.nih.gov/pubmed/29263915
http://dx.doi.org/10.1038/sigtrans.2017.12

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5661618/
https://www.ncbi.nlm.nih.gov/pubmed/29263915
http://dx.doi.org/10.1038/sigtrans.2017.12

Ejemplares similares